findmyKOL
Clinical trialNCT07044336RecruitingPhase 3Interventional

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

SponsorAstraZenecaEnrollment800Endometrial CancerMalignant Solid Tumour
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Brian Slomovitz, MD

    Icahn School of Medicine at Mount Sinai

    Principal Investigator
  • Nicole Concin, Prof.

    Head of the Division of General Gynecology and Gynecologic Oncology at the Department of Obstetrics and Gynecology of MedUni Vienna and University

    Principal Investigator
  • Stephanie Gaillard, MD, PhD

    Johns Hopkins University - Sidney Kimmel Comprehensive Cancer Center (SKCCC)

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

317 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina
  • Research Site

    Capital Federal, Argentina

    Recruiting
  • Research Site

    Ciudad Autonoma Buenos Aires, Argentina

    Recruiting
  • Research Site

    Ciudad de Buenos Aires, Argentina

    Recruiting
  • Research Site

    Cuidad Autónoma de Buenos Aire, Argentina

    Recruiting
  • Research Site

    Córdoba, Argentina

    Not, yet, recruiting
  • Research Site

    Córdoba, Argentina

    Recruiting
  • Research Site

    La Rioja, Argentina

    Recruiting
  • Research Site

    Pergamino, Argentina

    Recruiting
  • Research Site

    Viedma, Argentina

    Recruiting
Australia
  • Research Site

    Malvern, Australia

    Recruiting
  • Research Site

    Melbourne, Australia

    Recruiting
  • Research Site

    Randwick, Australia

    Recruiting
  • Research Site

    St Leonards, Australia

    Recruiting
  • Research Site

    Subiaco, Australia

    Recruiting
  • Research Site

    Westmead, Australia

    Recruiting
Austria
  • Research Site

    Graz, Austria

    Recruiting
  • Research Site

    Innsbruck, Austria

    Recruiting
  • Research Site

    Vienna, Austria

    Recruiting
Belgium
  • Research Site

    Brussels, Belgium

    Not, yet, recruiting
  • Research Site

    Brussels, Belgium

    Recruiting
  • Research Site

    Charleroi, Belgium

    Recruiting
  • Research Site

    Edegem, Belgium

    Not, yet, recruiting
  • Research Site

    Ghent, Belgium

    Recruiting
  • Research Site

    Ghent, Belgium

    Not, yet, recruiting
  • Research Site

    Leuven, Belgium

    Recruiting
  • Research Site

    Liège, Belgium

    Recruiting
  • Research Site

    Liège, Belgium

    Not, yet, recruiting
  • Research Site

    Namur, Belgium

    Recruiting
Brazil
  • Research Site

    Belo Horizonte, Brazil

    Not, yet, recruiting
  • Research Site

    Belém, Brazil

    Not, yet, recruiting
  • Research Site

    Bento Gonçalves, Brazil

    Not, yet, recruiting
  • Research Site

    Blumenau, Brazil

    Recruiting
  • Research Site

    Curitiba, Brazil

    Withdrawn
  • Research Site

    Curitiba, Brazil

    Recruiting
  • Research Site

    Florianópolis, Brazil

    Not, yet, recruiting
  • Research Site

    Joinville, Brazil

    Not, yet, recruiting
  • Research Site

    Natal, Brazil

    Recruiting
  • Research Site

    Porto Alegre, Brazil

    Not, yet, recruiting
  • Research Site

    Porto Alegre, Brazil

    Recruiting
  • Research Site

    Porto Alegre, Brazil

    Recruiting
277 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Aug 2025
Primary completion
15 Oct 2027
Completion
17 Jul 2029
Last update posted
10 Jun 2026
Registered enrollment
800
Registry id
NCT07044336

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.